Terms of Use
Last updated: August 12, 2026
These terms govern your use of the Pelma iOS app and this website, both published by Crolab (details on the Legal Notice page). By using Pelma you accept them.
What Pelma does
Pelma is a 12-week pelvic floor training programme. You answer a questionnaire, the app builds a schedule of guided exercises from your answers, and you log your leaks and dry days so you can see your own trend over time. Everything runs on your phone; your history syncs to your account so it survives a phone change.
Pelma is not a medical device and does not give medical advice. It does not diagnose, treat, cure or prevent anything, and it is not a substitute for a doctor, a midwife or a pelvic floor physiotherapist. The score the app shows you is a self-assessment tool to follow your own change — not a diagnosis.
Talk to a healthcare professional before starting if you are pregnant, less than six weeks postpartum, recovering from pelvic surgery, or if you have pain, bleeding, fever, or any symptom that is new to you. Stop and seek advice if an exercise hurts. Urinary symptoms can have causes that exercise will not fix.
Your account
You can use Pelma without an account. If you create one, you are responsible for keeping your credentials safe and for what happens under your account. Pelma is for adults; you must be at least 16 to create an account.
Subscriptions
Pelma is sold as an auto-renewing subscription through the App Store:
- Renewal is automatic. Your subscription renews at the end of each period unless you cancel.
- You are charged within 24 hours before the end of the current period, at the price and for the duration shown on the purchase screen.
- Prices and periods are those displayed in the app at the moment of purchase, in your local currency. The purchase screen always shows the exact price and duration before you confirm.
- Managing your subscription is done in your Apple account: Settings → your name → Subscriptions. We have no way to change or cancel it for you.
- Cancelling takes effect at the end of the current period. You keep access until then. Cancelling during a free trial ends access at the end of the trial.
- Free trial, when offered: it is announced on the purchase screen with its exact duration. If you do not cancel at least 24 hours before it ends, it converts into a paid subscription. Any unused portion of a trial is forfeited if you buy a subscription during it.
- Refunds are handled by Apple, under Apple's terms, at reportaproblem.apple.com. Crolab cannot issue a refund itself.
You can restore a previous purchase at any time with Restore purchases, on the purchase screen and in Settings.
Acceptable use
Do not try to break, reverse-engineer, scrape or resell the app, and do not use it to harm anyone. Do not present its output as a medical opinion, yours or anyone else's.
Availability
We do our best to keep Pelma working, but we do not promise it will be available without interruption. We may change or discontinue features. If we discontinue a paid feature during a period you have paid for, contact us.
Liability
Pelma is provided as an educational and wellness tool. To the extent permitted by law, Crolab is not liable for indirect damages, nor for any decision you take about your health on the basis of the app. Nothing here limits liability that cannot be limited by law, in particular in case of bodily injury caused by our fault. If you are a consumer, your statutory rights are unaffected.
Intellectual property
The app, its programme, its texts, its illustrations and its code belong to Crolab. Your subscription gives you a personal, non-transferable right to use them, nothing more.
Governing law
French law applies. If an amicable resolution cannot be reached, the French courts have jurisdiction. If you are a consumer, you keep the right to bring proceedings before the courts of your place of residence.
Changes
If we change these terms in a way that matters, we will update the date at the top and tell you in the app.
Contact
contact@pelma.app · See also the Privacy Policy and the Legal Notice.